olmesartan medoxomil
Generic: olmesartan medoxomil
Labeler: cadila pharmaceuticals limitedDrug Facts
Product Profile
Brand Name
olmesartan medoxomil
Generic Name
olmesartan medoxomil
Labeler
cadila pharmaceuticals limited
Dosage Form
TABLET, COATED
Routes
Active Ingredients
olmesartan medoxomil 5 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
71209-079
Product ID
71209-079_c8a58add-6c59-47ff-94e2-12d4e6513feb
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA210682
Listing Expiration
2026-12-31
Marketing Start
2025-01-01
Pharmacologic Class
Classes
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
71209079
Hyphenated Format
71209-079
Supplemental Identifiers
RxCUI
UNII
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
olmesartan medoxomil (source: ndc)
Generic Name
olmesartan medoxomil (source: ndc)
Application Number
ANDA210682 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 5 mg/1
Packaging
- 30 TABLET, COATED in 1 BOTTLE (71209-079-01)
- 90 TABLET, COATED in 1 BOTTLE (71209-079-04)
- 500 TABLET, COATED in 1 BOTTLE (71209-079-10)
- 1000 TABLET, COATED in 1 BOTTLE (71209-079-11)
Packages (4)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "c8a58add-6c59-47ff-94e2-12d4e6513feb", "openfda": {"unii": ["6M97XTV3HD"], "rxcui": ["349373", "349401", "349405"], "spl_set_id": ["c5416a9f-1dcc-4851-bbc0-6664d22fc8fa"], "manufacturer_name": ["Cadila Pharmaceuticals Limited"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET, COATED in 1 BOTTLE (71209-079-01)", "package_ndc": "71209-079-01", "marketing_start_date": "20250101"}, {"sample": false, "description": "90 TABLET, COATED in 1 BOTTLE (71209-079-04)", "package_ndc": "71209-079-04", "marketing_start_date": "20250101"}, {"sample": false, "description": "500 TABLET, COATED in 1 BOTTLE (71209-079-10)", "package_ndc": "71209-079-10", "marketing_start_date": "20250101"}, {"sample": false, "description": "1000 TABLET, COATED in 1 BOTTLE (71209-079-11)", "package_ndc": "71209-079-11", "marketing_start_date": "20250101"}], "brand_name": "Olmesartan Medoxomil", "product_id": "71209-079_c8a58add-6c59-47ff-94e2-12d4e6513feb", "dosage_form": "TABLET, COATED", "pharm_class": ["Angiotensin 2 Receptor Antagonists [MoA]", "Angiotensin 2 Receptor Blocker [EPC]"], "product_ndc": "71209-079", "generic_name": "Olmesartan Medoxomil", "labeler_name": "Cadila Pharmaceuticals Limited", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Olmesartan Medoxomil", "active_ingredients": [{"name": "OLMESARTAN MEDOXOMIL", "strength": "5 mg/1"}], "application_number": "ANDA210682", "marketing_category": "ANDA", "marketing_start_date": "20250101", "listing_expiration_date": "20261231"}